|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06609 HEARTCARE-B
Nominal 
54.650 -0.850 (-1.532%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 277,899 | 19.607% | 232,344 | 183,032 | 90,089 | 14,562 |
| Cost of Sales | (96,183) | 40.239% | (68,585) | (58,699) | (35,139) | (7,475) |
| Gross Profit | 181,716 | 10.966% | 163,759 | 124,333 | 54,950 | 7,087 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | (32,008) | (11,785) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (34,800) | 0 | 0 | |
| Profit / (Loss) before Taxation | (11,992) | -88.348% | (102,920) | (201,249) | (197,906) | (216,183) | |
| Taxation | (1,630) | -- | 8,908 | 865 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 3,681 | 2,519 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (13,622) | -85.510% | (94,012) | (200,384) | (194,225) | (213,664) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (7,017) | -22.353% | (9,037) | (12,995) | (3,132) | 1,430 |
| Depreciation & Amortisation | 32,109 | -0.465% | 32,259 | 31,787 | 12,203 | 8,385 |
| Directors' Emoluments | 5,596 | -11.090% | 6,294 | 6,407 | 36,148 | 120,569 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -36.000 | -85.425% | -247.000 | -524.000 | -582.000 | -978.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.086) | -- | (2.322) | (6.970) | (6.164) | (3.424) |
| NBV per share ($) | 27.353 | -- | 27.698 | 30.011 | 35.344 | -- |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 50,938 |
| %Change | -- |
| EPS / (LPS) | RMB 1.340 |
| NBV Per Share (¥) | RMB 28.703 |